REVA Medical, Inc.·4

Sep 11, 7:40 PM ET

REVA Medical, Inc. 4

4 · REVA Medical, Inc. · Filed Sep 11, 2015

Insider Transaction Report

Form 4
Period: 2015-09-10
Brandom Donald K.
VP, Biomaterials Product Dev
Transactions
  • Sale

    Common Stock

    2015-09-10$4.66/sh1,137.2$5,30391,412.8 total
Footnotes (2)
  • [F1]Represents the sale of 11,372 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
  • [F2]The sale was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the sale price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION